Certified Hospice and Palliative Assistant (CHPNA) Practice Test

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the Certified Hospice and Palliative Assistant Test. Study with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


How should breakthrough doses be handled during the equianalgesic conversion process?

  1. They should be ignored for calculation

  2. They are included in the total amount of the current drug

  3. They should be added only if severe pain is reported

  4. They are counted as half of the regular dose

The correct answer is: They are included in the total amount of the current drug

During the equianalgesic conversion process, breakthrough doses should be included in the total amount of the current drug to ensure an accurate assessment of the patient's pain management needs. This inclusion acknowledges the pain that is not adequately controlled by the current regimen and allows for a more precise calculation when converting to a different medication or dosage regimen. Breakthrough doses reflect the additional medication taken by the patient to manage pain that exceeds the baseline coverage, and failing to account for these doses could lead to under-treatment of pain. By incorporating them into the calculation, practitioners can provide a more effective and tailored pain management strategy for the patient, ensuring that both the regular and breakthrough doses contribute to the overall opioid requirement and avoiding potential gaps in analgesia.